BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120472
Published online Sep 15, 2026. doi: 10.4251/wjgo.120472
Dietary eicosapentaenoic and docosahexaenoic acids decrease prostanoids in the ileum of rats treated with irinotecan and 5-fluorouracil
Sarah R Parsons, Irma M Rivas-Serna, M Thomas Clandinin, Vera C Mazurak
Sarah R Parsons, Irma M Rivas-Serna, M Thomas Clandinin, Vera C Mazurak, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton T6G 2P5, Alberta, Canada
M Thomas Clandinin, Department of Medicine, University of Alberta, Edmonton T6G 2P5, Alberta, Canada
Author contributions: Mazurak VC supervised the project; Parsons SR conducted analysis and drafted the manuscript; Rivas-Serna IM performed the fatty acid and oxylipin analysis; Clandinin MT supervised lipid analysis; Parsons SR, Clandinin MT, and Mazurak VC conceptualized the study, and interpreted, reviewed, and edited the draft; all authors reviewed and approved the final submission.
Supported by Canadian Institutes of Health Research, No. PS165820.
Institutional review board statement: This study does not involve any human experiments.
Institutional animal care and use committee statement: All animal use was approved by the University of Alberta Animal Care Committee and conducted in accordance with Guidelines of the Canadian Council on Animal Care (No. AUP00003572).
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Data sharing statement: Dataset are available from the corresponding author (vmazurak@ualberta.ca) upon request.
Corresponding author: Vera C Mazurak, PhD, Professor, Department of Agricultural, Food and Nutritional Science, University of Alberta, 4-002F Li Ka Shing Centre for Health Research, Edmonton T6G 2P5, Alberta, Canada. vmazurak@ualberta.ca
Received: February 27, 2026
Revised: March 25, 2026
Accepted: July 28, 2026
Published online: September 15, 2026
Processing time: 179 Days and 22.3 Hours
Abstract
BACKGROUND

Irinotecan (CPT-11) and 5-fluorouracil (5-FU) are chemotherapeutic agents that disrupt the gastrointestinal tract. Prostanoids derived from arachidonic acid (AA) disrupt colonic water and electrolyte equilibrium and are implicated in chemotherapy-induced diarrhea. However, research assessing prostanoids in the ileum and effect of anti-inflammatory omega-3 polyunsaturated fatty acids are lacking.

AIM

To investigate effects of CPT-11 + 5-FU and dietary eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) on phospholipids and oxylipins in ileum tissue.

METHODS

Ward colon tumor was implanted and grew for approximately 2 weeks in Fischer rats fed a semi-purified standard diet prior to providing CPT-11 + 5-FU. On the same day as injecting CPT-11 (day 0), half of the rats were switched to a diet containing EPA and DHA. Rats were euthanized on day 0 (baseline) and following chemotherapy on days 2, 4, and 8 (n = 4-5/group).

RESULTS

CPT-11 + 5-FU increased oxylipins by day 2 derived from n-6 fatty acid (P = 0.002) and AA (P = 0.013), specifically 6-keto-prostaglandin (PG)-F (P < 0.0001), 8-hydroxyeicosatetraenoic acid (P = 0.006), and leukotriene B4 (P = 0.024). Feeding EPA + DHA increased EPA and DHA in ileal phospholipid by 40-fold and 2-fold from baseline to day 8, respectively, corresponding with a 10-fold increase in EPA metabolites and a 2-fold increase in DHA metabolites. EPA metabolites 15-hydroxyeicosapentaenoic acid (HEPE), 18-HEPE, and 17,18-dihydroxy-eicosatetraenoic acid; DHA metabolite 16-hydroxydocosahexaenoic acid; and AA metabolite lipoxin A4 increased by day 8 in animals fed the EPA + DHA diet compared to the control diet while 6-keto-PGF and PGD2 decreased below baseline.

CONCLUSION

Dietary EPA and DHA are incorporated into ileal membrane phospholipid, counteracting the chemotherapy-induced proinflammatory oxylipin profile, disrupting synthesis of prostanoids, and increasing synthesis of anti-inflammatory oxylipins.

Keywords: Ileum; Oxylipins; Phospholipid fatty acids; Rat; Tumor; Chemotherapy; Colorectal cancer; N-3 fatty acids; Fish oil; Irinotecan

Core Tip: The present study is the first to investigate n-6- and n-3-derived oxylipin levels from ileum tissue after irinotecan + 5-fluorouracil and modification by dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The arachidonic acid (AA) metabolite 6-keto-prostaglandin F implicated in inhibiting water absorption and electrolyte dysregulation increased after irinotecan + 5-fluorouracil. Dietary EPA and DHA markedly reduced 6-keto-prostaglandin F and several other prostanoids while increasing protective and resolving mediators, lipoxin A4 (AA-derived) and protectin-D1 (DHA-derived). Oxylipin potential to reduce the risk of chemotherapy-induced adverse effects, such as diarrhea, should be explored in models of multi-cycle chemotherapy.

Write to the Help Desk